Related Stories

Schedule II Stimulant Medications Are Subject to the Same Prescribing Limitation as Opioids - 06/11/2025

Spotty awareness of a DEA rule’s applicability to all Schedule II controlled substances – not just opioids – could leave some physicians who prescribe Schedule II controlled substances, which includes some common stimulants, in legal peril if they run askance of it, according to member reports to TMA.

Risk Management - 03/20/2025

Practice e-Tips on Risk Management

Practice E-Tips on Legal Topics - 03/17/2025

TMA Practice E-Tips on Legal Topics

Landmark Antitrust Settlement in BCBS Case Granted Preliminary Approval - 01/09/2025

Physicians can now file a claim in a $2.8 billion settlement fund given preliminary approval by a U.S. District Court involving Blue Cross Blue Shield. The final verdict is expected in July.

Abbott Signals Support for Opioid Crisis Interventions - 11/18/2024

Texas Gov. Greg Abbott recently listed the fentanyl crisis as one of seven “emergency” items this session, clearing a path toward passage of Texas Medical Association-backed legislation that aims to curb opioid-related deaths.

Abbott Signals Support for Opioid Crisis Interventions: Federal Efforts Also Are Underway - 11/18/2024

Texas Gov. Greg Abbott in February listed the fentanyl crisis as one of seven “emergency” items this session, clearing a path toward passage of Texas Medical Association-backed legislation that aims to curb opioid-related deaths.

TMA Considers Next Steps in Split Victory Over Payment Calculations in Surprise-Billing Arbitrations - 11/15/2024

After winning half the battle when the federal government dropped its appeal of two major components of the Texas Medical Association’s lawsuit early on, TMA is considering next steps after an appeals court upheld a portion of federal rules governing qualifying payment amount calculations in surprise-billing disputes that medicine says conflict with federal law and unfairly favor health plans.

High Court Decision Brings Favorable Wind for Physician Experts - 11/04/2024

The Texas Supreme Court has sided with the Texas Windstorm Insurance Association – and by extension, with medicine – in a case that impacts physicians who testify as expert witnesses in their own defense.

With FTC Rule in Limbo, Texas Legislature to Reconsider Noncompetes - 09/20/2024

Amid a pair of conflicting court rulings – one of which blocked a Federal Trade Commission (FTC) final rule banning most noncompete clauses – the Texas Senate is pondering related legislation for the upcoming session that could impact a significant number of physicians statewide.

Court Sides With Medical Examiner in Suit Over Autopsy - 08/09/2024

With the Texas Medical Association’s help, a Harris County medical examiner has won the latest battle in a lawsuit over an autopsy he performed following a woman’s 2007 shooting death.

TMA Wins Appeal Upholding Its Challenge to Skewed Federal Surprise Billing Rule - 08/05/2024

A federal appeals court handed a victory to medicine affirming the district court’s decision to strike down federal provisions that run counter to Congress' intent for implementing a key piece of the No Surprises Act: to operate an arbitration process that does not skew dispute resolutions and unfairly advantage health plans. Read more.

High Court Decision in Nondisclosure Case A Win For Medicine - 07/31/2024

The Texas Supreme Court sided with the Texas Medical Association in a nondisclosure case that TMA warned would have significant, troubling implications had it gone the wrong way.

Effects of Opioids and Nonsteroidal Anti-Inflammatory Drugs on Chronic Low Back Pain and Related Measures: Results from the PRECISION Pain Research Registry - 07/30/2024

Measuring treatments used by 202 patients with chronic low back pain in the PRECISION Pain Research Registry, this study determined the associations of opioid and nonsteroidal anti-inflammatory drug (NSAID) therapy with clinical status. More than one-fourth of patients did not use nonpharmacologic treatments for low back pain. Patients age 50-59 and 60-79 years old were more likely to use opioids than younger patients. Patients using opioids reported greater pain and back-related disability than did patients using NSAIDs. Patients concurrently using opioids and NSAIDs reported greater back-related disability and poorer quality of life than did patients using no or other pharmacologic therapy. No significant associations between pharmacologic therapy and clinical status remained after controlling for potential confounders. Neither opioids nor opioids combined with NSAIDs were more effective than just NSAIDs. Greater use of nonpharmacologic therapies and better second-line, nonopioid ph...

More Work Needed to Protect Texas Physicians - 06/28/2024

Following the Texas Medical Board’s newly adopted rules on abortion ban exceptions, the Texas Medical Association continues its advocacy for physicians performing abortions to treat a medical emergency under the state’s overlapping abortion laws.

New TMA Policy: Reduce Fentanyl Overdoses with Improved Naloxone Access - 06/24/2024

Over a 27-hour period this spring, the city of Austin saw nine people die across 79 separate overdose incidents, reflecting the severity of the statewide fentanyl crisis. Policy approved by the Texas Medical Association’s House of Delegates in May anticipated the problem and promotes one of the most effective solutions – increased education about and distribution of naloxone, an opioid overdose reversal drug.

TMB Proposed Rules on Abortion Ban Exceptions Invite TMA Opposition - 05/14/2024

The Texas Medical Board (TMB) recently released proposed rules intended to clarify exceptions to the state’s overlapping abortion laws. But TMA argues the proposal could exacerbate physician confusion, administrative burden on practices, and patient care delays. Read more.

Seeking Balance: TMA Opposes Feds' Implementation of the No Surprises Act - 04/09/2024

The Texas Medical Association supported the patient protections in the federal No Surprises Act but also knew from the beginning that the law's payment arbitration provisions were flawed and could give insurers an advantage.

RICO Settlements: TMA's Leadership Against Payer Abuses Resulted in Relief, Reform - 04/09/2024

Back in 2001, the Texas Medical Association and the other plaintiffs alleged the nation’s major health plans had conspired to delay and reduce payments to clinicians and hospitals; the resulting lawsuits, brought under the federal Racketeer Influenced and Corrupt Organizations Act (RICO), represented a watershed moment in TMA history.

Exceptional Circumstances: TMA Advocates “Legislative Clarity” Amid State Abortion Bans - 03/05/2024

TMA advocates “legislative clarity” amid state abortion bans.

Physicians’ DEA Registration Now Requires Training on Substance Use Disorder - 01/03/2024

Physicians who must register or renew their registration for a Drug Enforcement Administration license will face a new requirement as of June 27: To register, they will have attest to taking a one-time, eight-hour training on how to treat patients with opioid or other substance use disorders.

Feds Extend Telemedicine Prescribing Flexibilities Through 2024 - 11/10/2023

With permanent telehealth prescribing policies still under consideration, the U.S. Drug Enforcement Administration (DEA) again has extended temporary pandemic-era telehealth flexibilities to allow physicians to virtually prescribe certain controlled medications, now through Dec. 31, 2024.

CDC Grant Funds Drug Overdose Data Collection in Texas - 10/30/2023

A nearly $4 million grant from the Centers for Disease Control and Prevention could give Texas physicians new tools to handle national opioid and mental health crises, which have made it difficult to identify patients at risk for substance use disorders.

Help Promote National Drug Prescription Take Back Day on Oct. 28 - 10/19/2023

Prescription Drug Take Back Day, which allows people to dispose of prescription drugs safely and anonymously, is scheduled for Oct. 26 at locations throughout the state.

TMA Wins Two More Surprise Billing Lawsuits; CMS Suspends Arbitrations - 10/03/2023

Marking a fourth victory for the Texas Medical Association in as many lawsuits, a court on Aug. 24 struck down a large portion of the regulations setting forth a methodology insurers use to calculate the qualifying payment amount, or QPA, used in surprise-billing disputes – part of a series of federal rules TMA has long argued skew the arbitration process in insurers’ favor.

Noncompete Concerns Spark Ongoing TMA Advocacy, Resources - 09/19/2023

The Texas Medical Association continues to receive reports of physician concerns over noncompete agreements, underscoring medicine’s ongoing legislative and regulatory advocacy efforts to strike a balance that works for physician employers and employed physicians alike.